Improving CNNs classification with pathologist-based expertise: the renal cell carcinoma case study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 09 2023
Historique:
received: 27 01 2023
accepted: 15 09 2023
medline: 25 9 2023
pubmed: 24 9 2023
entrez: 23 9 2023
Statut: epublish

Résumé

The prognosis of renal cell carcinoma (RCC) malignant neoplasms deeply relies on an accurate determination of the histological subtype, which currently involves the light microscopy visual analysis of histological slides, considering notably tumor architecture and cytology. RCC subtyping is therefore a time-consuming and tedious process, sometimes requiring expert review, with great impact on diagnosis, prognosis and treatment of RCC neoplasms. In this study, we investigate the automatic RCC subtyping classification of 91 patients, diagnosed with clear cell RCC, papillary RCC, chromophobe RCC, or renal oncocytoma, through deep learning based methodologies. We show how the classification performance of several state-of-the-art Convolutional Neural Networks (CNNs) are perfectible among the different RCC subtypes. Thus, we introduce a new classification model leveraging a combination of supervised deep learning models (specifically CNNs) and pathologist's expertise, giving birth to a hybrid approach that we termed ExpertDeepTree (ExpertDT). Our findings prove ExpertDT's superior capability in the RCC subtyping task, with respect to traditional CNNs, and suggest that introducing some expert-based knowledge into deep learning models may be a valuable solution for complex classification cases.

Identifiants

pubmed: 37741835
doi: 10.1038/s41598-023-42847-y
pii: 10.1038/s41598-023-42847-y
pmc: PMC10517931
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15887

Informations de copyright

© 2023. Springer Nature Limited.

Références

Cancer Med. 2014 Dec;3(6):1485-92
pubmed: 25124064
IEEE Trans Med Imaging. 2021 Oct;40(10):2845-2856
pubmed: 33523807
Int J Cancer. 2021 Feb 1;148(3):780-790
pubmed: 32895914
BMC Bioinformatics. 2022 Jul 24;23(1):295
pubmed: 35871688
Sci Rep. 2017 Apr 18;7:46450
pubmed: 28418027
Arch Pathol Lab Med. 2011 Jan;135(1):92-109
pubmed: 21204715
Virchows Arch. 2018 Feb;472(2):187-194
pubmed: 28842744
Neural Netw. 2018 Oct;106:249-259
pubmed: 30092410
Cancers (Basel). 2022 Jul 12;14(14):
pubmed: 35884442
Sci Rep. 2019 Feb 6;9(1):1483
pubmed: 30728398
Nat Commun. 2020 Apr 14;11(1):1778
pubmed: 32286325
Sci Rep. 2019 Jul 19;9(1):10509
pubmed: 31324828
Urology. 2020 Oct;144:152-157
pubmed: 32711010
Bioinformatics. 2020 May 1;36(10):3248-3250
pubmed: 32016382
Med Image Anal. 2022 Jan;75:102256
pubmed: 34717189
Biochim Biophys Acta. 1975 Oct 20;405(2):442-51
pubmed: 1180967
IEEE Trans Neural Netw Learn Syst. 2018 Oct;29(10):4550-4568
pubmed: 29989994
Am J Clin Pathol. 1998 Dec;110(6):782-7
pubmed: 9844591
Sci Rep. 2021 Mar 29;11(1):7080
pubmed: 33782535
AJR Am J Roentgenol. 2010 Dec;195(6):W421-7
pubmed: 21098174

Auteurs

Francesco Ponzio (F)

Interuniversity Department of Regional and Urban Studies and Planning, Politecnico di Torino, Turin, Italy. francesco.ponzio@polito.it.

Xavier Descombes (X)

Université Côte d'Azur/INRIA/CNRS, Sophia Antipolis, France.

Damien Ambrosetti (D)

Department of Pathology, CHU Nice, Université Côte d'Azur, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH